Serum Immunoglobulin Testing
Serum IgA levels are measured using quantitative immunoglobulin assays, most commonly nephelometry or enzyme-linked immunosorbent assay (ELISA), performed on venous blood samples.
Standard Testing Methods
The primary laboratory methods for measuring IgA include:
Nephelometry: This is the standard clinical laboratory method that measures IgG, IgA, and IgM simultaneously from serum samples 1. This technique is widely available and serves as the reference standard in most clinical settings.
ELISA-based assays: These provide sensitive quantification of immunoglobulin levels and are particularly useful when measuring low concentrations 2, 3.
Important Technical Considerations
Detection Limits Matter for Diagnosis
A critical caveat when ordering IgA testing: most routine clinical laboratories cannot accurately measure IgA levels below 7 mg/dL 4. This limitation has significant diagnostic implications:
- For diagnosing selective IgA deficiency (SIGAD), you need a laboratory capable of detecting levels <7 mg/dL
- Approximately two-thirds of patients with IgA <7 mg/dL have detectable low levels, while one-third have completely absent IgA
- Specialty laboratories offer more sensitive assays that can distinguish between very low and truly absent IgA 4
Age-Specific Reference Ranges
When interpreting results, always use age-appropriate reference ranges 4. This is particularly important in:
- Infants and young children: IgA levels normally increase gradually through childhood
- Transient hypogammaglobulinemia of infancy: Requires serial measurements over time, as IgG (and sometimes IgA/IgM) may not normalize until 27-59 months of age 4
Alternative Testing Approaches
Dried blood spot (DBS) testing is an emerging option for screening patients ≥16 years of age 2. This method:
- Demonstrates good correlation with standard nephelometry (correlation coefficient 0.918 for IgA)
- Allows convenient sample collection and shipping at room temperature
- Is stable for 14 days at ambient temperature
- May be useful for targeted screening in remote or resource-limited settings
Clinical Pitfall to Avoid
Always obtain a medication history before interpreting low IgA levels 4. Drug-induced IgA deficiency can be caused by:
- Anticonvulsants (phenytoin, carbamazepine, valproic acid, zonisamide)
- Disease-modifying agents (sulfasalazine, gold, penicillamine, hydroxychloroquine)
- NSAIDs
This is often reversible with drug cessation, making it essential to identify before labeling a patient with primary immunodeficiency.